drug
as of 2026-07-01Cognitive Behavioral Therapy
cognitive behavioral therapy
MeSH D015928
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by Ciusss de L'Est de l'Île de Montréal
13 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
BEHAVIORAL
Indications
Investigational (via trials)
SchizophreniaSubstance-Related DisordersSchizophrenia DisordersDepressionPremature BirthPsychosisTreatment-resistant SchizophreniaMedication AdherenceParanoid DisordersSchizophrenia Spectrum and Other Psychotic DisordersPatient ComplianceDepressive SymptomsProdromal SymptomsBipolar DisorderAPSMental Disorders
Trials
13
Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy
NCT06835556—Recruiting
Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial)
NCT03906435—Recruiting
Cognitive Behavioral Therapy Added to Risperidone for Schizophrenia
NCT07609953—Completed
Comparaison of Avatar Therapy to Cognitive Behavioral Therapy in Schizophrenia With Treatment Refractory Hallucinations
NCT04054778—Unknown
Avatar Therapy in Comparison to Cognitive Behavioral Therapy for Treatment-resistant Schizophrenia
NCT03585127—Completed
HOPE TEAM - Clinical High Risk Group CBSST
NCT03738046—Withdrawn
Cognitive Behavioral Therapy for the Prevention of Paranoia in Adolescents at High Risk
NCT01923701—Completed
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
NCT01981759Phase 4Completed
Cognitive Behavioral Therapy for Patients With an Early Psychosis
NCT01511406Phase 2Completed
Medication Adherence in Schizophrenia: Development of a CBT-Based Intervention
NCT00980252—Completed
Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for Schizophrenia
NCT00742079Phase 4Completed
Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
NCT00012558—Completed
Trial of Cognitive Behavioral Therapy for Schizophrenia
NCT00300651Phase 3Unknown
KOLs & investigators
12
Donald C. Goff, MDKOL score 8
Peter Handest, MD, Ph.d.KOL score 5
Professor Gary Donohoe, Ph.D.KOL score 5
Michael C Davis, M.D., Ph.D.KOL score 5
Jan I Røssberg, MD, PhDKOL score 5
Alexandre Dumais, MD, PhDKOL score 5
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
trial
indication
indication
indication
indication
indication
KOL
Donald C. Goff, MD
personKOL score 8
Peter Handest, MD, Ph.d.
personKOL score 5
Professor Gary Donohoe, Ph.D.
personKOL score 5
Michael C Davis, M.D., Ph.D.
personKOL score 5